Selectable marker genes

US10752913B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10752913-B2
Application numberUS-51790607-A
CountryUS
Kind codeB2
Filing dateDec 7, 2007
Priority dateDec 7, 2006
Publication dateAug 25, 2020
Grant dateAug 25, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A phosphinothricin-resistant transgenic plant cell comprising between 1 and 3 copies of the polynucleotide of SEQ ID NO:3 integrated in the genomic DNA of the plant cell, wherein the plant cell is resistant to glufosinate when applied at a rate of 560 g ai/ha. 2. A method of selecting for a transgenic plant cell, the method comprising: transforming a plurality of plant cells with a low copy number vector comprising a polynucleotide operably linked to a promoter operable in the plant cells, wherein the polynucleotide is SEQ ID NO:3, thereby producing transgenic plant cells comprising a low copy number of the polynucleotide; and growing the plurality of plant cells in a concentration of bialaphos or glufosinate that permits cells that express the polynucleotide to grow, while killing or inhibiting the growth of cells that do not express the polynucleotide, thereby selecting a transgenic plant cell that is resistant to glufosinate when applied at a rate of 560 g ai/ha. 3. The method of claim 2 , wherein the method further comprises regenerating a plant from the transgenic plant cell. 4. A phosphinothricin-resistant plant comprising a plurality of the phosphinothricin-resistant transgenic plant cells of claim 1 , wherein the plant is resistant to glufosinate when applied at a rate of 560 g ai/ha. 5. A seed of the plant of claim 4 . 6. The phosphinothricin-resistant transgenic plant cell of claim 1 , wherein the cell further comprises an insect-resistance gene derived from an organism selected from the group consisting of Bacillus thruingiensis, Plotorhabdus , and Xenorhabdus. 7. The phosphinothricin-resistant transgenic plant cell of claim 1 , wherein the cell further comprises a second herbicide-resistance gene. 8. The phosphinothricin-resistant plant of claim 4 , wherein the plant further comprises a herbicide resistance gene selected from the group consisting of AAD-1 and AAD-12, and wherein the plant is resistant to 2,4-D. 9. The phosphinothricin-resistant plant of claim 4 , wherein the plant further comprises an insect-resistance gene from an organism selected from the group consisting of Bacillus thruingiensis, Photorhabdus , and Xenorhabdus. 10. The phosphinothricin-resistant plant of claim 4 , wherein the plant further comprises a gene for an agronomic trait selected from the group consisting of fungal resistance, stress tolerance, increased yield, improved oil profile, improved fiber quality, viral resistance, delayed ripening, cold tolerance, and salt tolerance. 11. The phosphinothricin-resistant plant of claim 4 , wherein the plant is soybean. 12. The phosphinothricin-resistant plant of claim 4 , wherein the plant is corn. 13. The phosphinothricin-resistant transgenic plant cell of claim 1 , wherein the plant cell comprises a single copy of the polynucleotide of SEQ ID NO:3 integrated in the genome of the plant cell. 14. The phosphinothricin-resistant plant of claim 4 , wherein the plant is resistant to glufosinate when applied at a rate of 1,120 g ai/ha. 15. The phosphinothricin-resistant plant of claim 14 , wherein the plant is soybean. 16. The phosphinothricin-resistant plant of claim 14 , wherein the plant is corn.

Assignees

Inventors

Classifications

  • Phosphinothricin acetyltransferase (2.3.1.183) · CPC title

  • Glyphosate · CPC title

  • C12N15/821Primary

    Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers · CPC title

  • Phosphinotricin · CPC title

  • Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10752913B2 cover?
The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialap…
Who is the assignee on this patent?
Lira Justin M, Wright Terry R, Russell Sean M, and 6 more
What technology area does this patent fall under?
Primary CPC classification C12N15/821. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).